Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a "brain pacemaker"), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson's Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.
This report contains market size and forecasts of Deep Brain Stimulation in Parkinson's Disease in Global, including the following market information:
Global Deep Brain Stimulation in Parkinson's Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Deep Brain Stimulation in Parkinson's Disease market was valued at 862.2 million in 2021 and is projected to reach US$ 1555.5 million by 2028, at a CAGR of 8.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dual Channel Deep brain Stimulator Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Deep Brain Stimulation in Parkinson's Disease include Abbott, Aleva Neurotherapeutics SA, Beijing PINS Medical Co, Boston Scientific Corporation, Functional Neuromodulation Ltd, Medtronic, Neuronetics Inc., NeuroPace Inc. and Nevro Corporation. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deep Brain Stimulation in Parkinson's Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deep Brain Stimulation in Parkinson's Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Deep Brain Stimulation in Parkinson's Disease Market Segment Percentages, by Type, 2021 (%)
Dual Channel Deep brain Stimulator
Single Channel Deep brain Stimulator
Global Deep Brain Stimulation in Parkinson's Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Deep Brain Stimulation in Parkinson's Disease Market Segment Percentages, by Application, 2021 (%)
Hospitals
Neurology Clinics
Research Centers
Global Deep Brain Stimulation in Parkinson's Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Deep Brain Stimulation in Parkinson's Disease Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Deep Brain Stimulation in Parkinson's Disease revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Deep Brain Stimulation in Parkinson's Disease revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Aleva Neurotherapeutics SA
Beijing PINS Medical Co
Boston Scientific Corporation
Functional Neuromodulation Ltd
Medtronic
Neuronetics Inc.
NeuroPace Inc.
Nevro Corporation